Supply disruption alert: Discontinuation of Morphine sulphate (MST CONTINUS) 20mg, 30mg, 60mg, 100mg and 200mg prolonged release granules for oral suspension

All strengths of MST Continus® prolonged-release granules for oral suspension are being permanently discontinued during 2021 due to difficulty sourcing a key excipient.  Alternative morphine presentations remain available and will be able to support increased demand.

Medicines and Healthcare products Regulatory Agency